The Best ECG Lead for Predicting the Risk of Drug-Induced Torsade De Pointes Using Corrected QT Interval: A Comparative Prognostic Study
Archives of Academic Emergency Medicine,
Vol. 13 No. 1 (2025),
6 September 2025
,
Page e5
https://doi.org/10.22037/aaem.v13i1.2323
Abstract
Introduction: Torsade de pointes (TdP) is a deadly complication from drug-induced QT prolongation. Each of the 12 lead of an electrocardiogram (ECG) has a different length of QT interval, and thus might have a different performance in TdP prediction. This study aimed to determine the best ECG lead or set of leads in this regard.
Methods: This is a comparative prognostic accuracy study using a two-gate data gathering design. The population in this study was from two sources, a case group (Patients who had drug-induced TdP, which were identified through a systematic Medline search) and a control group (those who overdosed on QT-prolonging drugs, which included patients who were under the consultation of Medical Toxicology Services). The areas under the receiver operating characteristic curve (AUROC) of heart rate-corrected QT (QTc) in each single ECG lead and of a mean/median QTc from a set of ECG leads (17 index test) in predicting the risk of TdP were calculated and compared with each other, trying to find the best lead for this propose. QTc Interval measurements were done by four investigators (Interrater reliabilities 0.95).
Results: Finally, we included 136 and 148 ECGs from TdP cases and controls, respectively. V3 lead had the highest frequency of longest QTc interval, among the leads. The lead having the longest QTc yielded the greatest AUROC in predicting TdP regardless of QT correction formulas (QTcFRA=0.9915, QTcRTH=0.9893, QTcBZT=0.9904). The mean QTc of 3 leads (lead II, plus any two of leads V2-V4), and a median QTc of 6 leads (I, II, aVF, V2, V4, V6) provided similar overall performance for TdP prediction (regardless of the type of QTc formula).
Conclusion: The longest QTc provided the greatest AUROC in predicting drug-induced TdP, however, the longest QTc is not located in a fixed individual lead in any patient. A less time-consuming method with comparable performance to that of the longest QTc was to use a mean QTc from 3 leads (lead II, plus any two of leads V2-V4). The potential clinical impact of this finding needs to be verified in a prospective cohort study.
- Long QT syndrome
- Area under curve
- QT measurement
- Torsade de Pointes
- 12 Lead EKG
How to Cite
References
Isbister GK. Risk assessment of drug-induced QT prolongation. Aust Prescr. 2015;38(1):20–4.
Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010 Mar;121(8):1047–60.
Li M, Ramos LG. Drug-induced QT prolongation and torsades de pointes. P T. 2017;42(7):473–7.
Othong R, Wattanasansomboon S, Kruutsaha T, Chesson D, Vallibhakara SA, Kazzi Z. Utility of QT interval corrected by Rautaharju method to predict drug-induced torsade de pointes. Clin Toxicol. 2019;57(4):234–9.
Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart. 2003 Nov;89(11):1363–72.
Isbister GK, Page CB. Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice. Br J Clin Pharmacol. 2013 Jul;76(1):48–57.
Kan AA, de Lange DW, Donker DW, Meulenbelt J. Management of prolonged QT interval and torsades de pointes in the intoxicated patient. Neth J Med. 2014 Apr;72(3):119–26.
Lund K, Perkiömäki JS, Brohet C, Elming H, Zaïdi M, Torp-Pedersen C, et al. The prognostic accuracy of different QT interval measures. Ann Noninvasive Electrocardiol. 2002;7(1):10–6.
Lepeschkin E, Surawicz B. The measurement of the Q-T interval of the electrocardiogram. Circulation. 1952;6(3):378–88.
Lanjewar P, Pathak V, Lokhandwala Y. Issues in QT interval measurement. Indian Pacing Electrophysiol J. 2004;4(4):156–61.
Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R, Deal BJ, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias C. J Am Coll Cardiol. 2009 Mar;53(11):982–91.
Postema PG, Wilde AAM. The measurement of the QT interval. Curr Cardiol Rev. 2014;10(3):287–94.
Sharma S, Drezner JA, Baggish A, Papadakis M, Wilson MG, Prutkin JM, et al. International recommendations for electrocardiographic interpretation in athletes. Eur Heart J. 2018;39(16):1466–80.
Woosley R, Heise C, Romero K. QT drug lists [Internet]. CredibleMeds®. 2021 [cited 2019 Mar 29]. Available from: www.Crediblemeds.org
Newman TB, Browner WS, Cummings SR, Hulley SB. Designing studies of medical tests. In: Hulley SB, Cummings SR, Browner WS, Grady DG, Newman TB, editors. Designing clinical research. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 171–91.
Rutjes AWS, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PMM. Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem. 2005 Aug;51(8):1335–41.
Pepe MS, Fan J, Seymour CW, Li C, Huang Y, Feng Z. Biases introduced by choosing controls to match risk factors of cases in biomarker research. Clin Chem. 2012 Aug;58(8):1242–51.
Pencina MJ. Caution is needed in the interpretation of added value of biomarkers analyzed in matched case control studies. Clin Chem. 2012 Aug;58(8):1176–8.
Othong R, Devlin JJ, Kazzi ZN. Medical toxicologists’ practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region. Clin Toxicol. 2015;53(4):204–9.
Vandenberk B, Vandael E, Robyns T, Vandenberghe J, Garweg C, Foulon V, et al. Which QT correction formulae to use for QT monitoring? J Am Heart Assoc. 2016;5(6):e003264.
Hajian-Tilaki K. Sample size estimation in diagnostic test studies of biomedical informatics. J Biomed Inform. 2014;48:193–204.
Kasamaki Y, Ozawa Y, Ohta M, Sezai A, Yamaki T, Kaneko M, et al. Automated versus manual measurement of the QT interval and corrected QT interval. Ann Noninvasive Electrocardiol. 2011;16(2):156–64.
- Abstract Viewed: 452 times
- pdf Downloaded: 1520 times
Download Statastics
Make a Submission
SJR
COPE
